Menu
Your Cart

Magnetic Nanoparticles

Magnetic Nanoparticles
Apostle MiniEnrich for Enrichment of Short DNA fragments for NIPT and Oncology ApplicationsPrecise DNA sizing can boost sequencing efficiency, reduce cost, improve data quality, and even allow sequencing of low-input samples, while current pervasive DNA sizing approaches are incap- able of different..
$270.00
Apostle MiniEnrich for Enrichment of Short DNA fragments for NIPT and Oncology ApplicationsPrecise DNA sizing can boost sequencing efficiency, reduce cost, improve data quality, and even allow sequencing of low-input samples, while current pervasive DNA sizing approaches are incap- able of different..
$859.14
Apostle MiniMax technology ensures precise capture and separation of DNA, RNA, and other biomolecules. This is achieved through Apostle’s novel proprietary MiniMax magnetic nanoparticles with innovative features:Novel material composition and surface chemistry - completely distinct from the conventi..
$864.00
Apostle MiniMax technology ensures precise capture and separation of DNA, RNA, and other biomolecules. This is achieved through Apostle’s novel proprietary MiniMax magnetic nanoparticles with innovative features:Novel material composition and surface chemistry - completely distinct from the conventi..
$3,434.40
Next-generation purification, size selection, and long-read size selection.The Apostle MiniEnrich Size Selection Beads is designed for size selection of DNA fragments from a mixture of DNA with various sizes, which potentially benefits downstream assays like NGS and other molecular biology workflows..
$415.04
Next-generation purification, size selection, and long-read size selection.The Apostle MiniEnrich Purification Beads is designed for purification and clean-up of DNA fragments from the contaminants in NGS and molecular biology workflows. It can be used on samples after DNA isolation, fragmentation, ..
$415.04
Showing 1 to 6 of 6 (1 Pages)
With the help of Apostle MiniMax cfDNA Isolation Technology, a recent clinical study demonstrated the clinical validity of the circulating cell-free DNA for hepatocellular carcinoma (HCC) detection with high sensitivity and specificity, published in Science Translational Medicine.